Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 50 of 100 for:    "Dengue Hemorrhagic Fever"

Long-Term Safety and Antibody Persistence of TDV and Impact of a Booster Dose

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03999996
Recruitment Status : Not yet recruiting
First Posted : June 27, 2019
Last Update Posted : June 27, 2019
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : March 30, 2023
  Estimated Study Completion Date : December 7, 2023